Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Raymond Yan-Kit Kwong, M.D.

Co-Author

This page shows the publications co-authored by Raymond Kwong and Tomas Neilan.
Connection Strength

7.899
  1. The Authors Reply. JACC Cardiovasc Imaging. 2016 Mar; 9(3):327-8.
    View in: PubMed
    Score: 0.695
  2. Late gadolinium enhancement among survivors of sudden cardiac arrest. JACC Cardiovasc Imaging. 2015 Apr; 8(4):414-423.
    View in: PubMed
    Score: 0.650
  3. Reply: prognostic value of myocardial scar in atrial fibrillation. J Am Coll Cardiol. 2014 May 20; 63(19):2055.
    View in: PubMed
    Score: 0.604
  4. Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation. JACC Cardiovasc Imaging. 2014 Jan; 7(1):1-11.
    View in: PubMed
    Score: 0.594
  5. Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc. 2013 Nov 25; 2(6):e000421.
    View in: PubMed
    Score: 0.594
  6. The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation . J Am Coll Cardiol. 2013 Dec 10; 62(23):2205-14.
    View in: PubMed
    Score: 0.584
  7. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging. 2013 Sep; 6(9):944-54.
    View in: PubMed
    Score: 0.582
  8. Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines. Am J Cardiol. 2012 Dec 01; 110(11):1679-86.
    View in: PubMed
    Score: 0.544
  9. Characterizing post-myocardial infarction microvascular obstruction by ECG: we could learn more from cardiac magnetic resonance imaging. Rev Esp Cardiol. 2010 Oct; 63(10):1120-2.
    View in: PubMed
    Score: 0.478
  10. Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis. J Am Coll Cardiol. 2021 Mar 30; 77(12):1503-1516.
    View in: PubMed
    Score: 0.247
  11. Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis. Eur Heart J. 2020 05 07; 41(18):1733-1743.
    View in: PubMed
    Score: 0.232
  12. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy. JACC Cardiovasc Imaging. 2019 08; 12(8 Pt 2):1659-1669.
    View in: PubMed
    Score: 0.210
  13. Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging. Circ Cardiovasc Imaging. 2016 Dec; 9(12).
    View in: PubMed
    Score: 0.183
  14. Effect of Late Gadolinium Enhancement on the Recovery of Left Ventricular Systolic Function After Pulmonary Vein Isolation. J Am Heart Assoc. 2016 Sep 26; 5(9).
    View in: PubMed
    Score: 0.181
  15. Infarct tissue heterogeneity by contrast-enhanced magnetic resonance imaging is a novel predictor of mortality in patients with chronic coronary artery disease and left ventricular dysfunction. Circ Cardiovasc Imaging. 2014 Nov; 7(6):887-894.
    View in: PubMed
    Score: 0.158
  16. T1 measurements for detection of expansion of the myocardial extracellular volume in chronic obstructive pulmonary disease. Can J Cardiol. 2014 Dec; 30(12):1668-75.
    View in: PubMed
    Score: 0.156
  17. Left atrial passive emptying function determined by cardiac magnetic resonance predicts atrial fibrillation recurrence after pulmonary vein isolation. Circ Cardiovasc Imaging. 2014 Jul; 7(4):586-92.
    View in: PubMed
    Score: 0.154
  18. Vasodilator stress perfusion CMR imaging is feasible and prognostic in obese patients. JACC Cardiovasc Imaging. 2014 May; 7(5):462-72.
    View in: PubMed
    Score: 0.152
  19. Obesity and sleep apnea are independently associated with adverse left ventricular remodeling and clinical outcome in patients with atrial fibrillation and preserved ventricular function. Am Heart J. 2014 Apr; 167(4):620-6.
    View in: PubMed
    Score: 0.150
  20. Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease. Circulation. 2013 Aug 06; 128(6):605-14.
    View in: PubMed
    Score: 0.144
  21. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. JACC Cardiovasc Imaging. 2013 Jun; 6(6):672-83.
    View in: PubMed
    Score: 0.143
  22. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ Cardiovasc Imaging. 2013 May 01; 6(3):415-22.
    View in: PubMed
    Score: 0.142
  23. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol. 2013 Mar 01; 111(5):717-22.
    View in: PubMed
    Score: 0.139
  24. Cardiac magnetic resonance assessment of interstitial myocardial fibrosis and cardiomyocyte hypertrophy in hypertensive mice treated with spironolactone. J Am Heart Assoc. 2014 Jun 25; 3(3):e000790.
    View in: PubMed
    Score: 0.039
  25. Myocardial tissue remodeling in adolescent obesity. J Am Heart Assoc. 2013 Aug 20; 2(4):e000279.
    View in: PubMed
    Score: 0.036
  26. Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling. Circulation. 2013 Sep 10; 128(11):1225-33.
    View in: PubMed
    Score: 0.036
  27. Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus. Am J Cardiol. 2013 Jul 01; 112(1):73-8.
    View in: PubMed
    Score: 0.036
  28. Evaluation of right ventricular remodeling using cardiac magnetic resonance imaging in co-existent chronic obstructive pulmonary disease and obstructive sleep apnea. COPD. 2013 Feb; 10(1):4-10.
    View in: PubMed
    Score: 0.035
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.